Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG/IgM ELISA for Sero-Diagnosis
Pathogens · 2024
DOI: 10.3390/pathogens13070582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Jiansheng Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Guizhou University, Guiyang 550002, China. Hauptthemen laut MEDLINE: Enzyme-Linked Immunosorbent Assay, Rift Valley fever virus, Antibodies, Monoclonal, Rift Valley Fever. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the doctor′s funding of Guizhou Provincial People′s Hospital GSYSBS.
Abstract (Originalsprache)
Introduction
Rift Valley fever virus (RVFV) belonging to the Phenuiviridae family is responsible for a zoonotic disease called Rift Valley fever (RVF). Currently, RVFV has spread from Africa to Asia, and due to its ability to cause high mortality rates, it has significantly impacted human health and economic development in many societies. Highly specific and sensitive systems for sero-diagnosis of RVFV infection are needed for clinical use.
Method
BALB/c mice were immunized with recombinant RVFV nucleocapsid (rRVFV-N) protein and the spleen cells fused with SP2/0 myeloma cells to create hybridoma cell lines. The secreted monoclonal antibodies (MAbs) were purified and characterized. Enzyme-linked immunosorbent assay (ELISA) systems for the detection of IgG and IgM using the new MAbs were established and evaluated. Serum samples from 96 volunteers and 93 patients of suspected RVF from Kenya were tested compared with the ELISA systems based on inactivated viruses and the rabbit polyclonal antibody.
Result
Three monoclonal antibodies against rRVFV-N protein were established. The performance of the MAb-based sandwich IgG ELISA and the IgM capture ELISA perfectly matched the ELISA systems using the inactivated virus or the polyclonal antibody.
Conclusions
Recombinant RVFV-N protein-specific MAbs were developed and they offer useful tools for RVFV studies. The MAb-based ELISA systems for detecting IgG and IgM offer safe and useful options for diagnosing RVFV infections in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Guizhou University, Guiyang 550002, China.
- Kenya Medical Research Institute, Nairobi 54840-00200, Kenya.
- Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4, Sakamoto, Nagasaki 852-8523, Japan.
- NHC Key Laboratory of Pulmonary Immunological Diseases, Guizhou Provincial People's Hospital, Guiyang 550002, China.
- Guizhou Provincial People's Hospital, Guizhou University, Guiyang 550002, China.
ORCID-Profile: Ferdinard Adungo, Allan Ole Kwallah, Fuxun Yu
Förderung
- National Natural Science Foundation of China
- the doctor′s funding of Guizhou Provincial People′s Hospital GSYSBS
Zitieren
APA
Huang, J., Adungo, F., Konongoi, S. L., Inoue, S., Zhan, L., Sang, R., Ashur, S., Kwallah, A. O., Mwau, M., Morita, K., & Yu, F. (2024). Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG/IgM ELISA for Sero-Diagnosis. Pathogens. https://doi.org/10.3390/pathogens13070582
Vancouver
Huang J, Adungo F, Konongoi SL, Inoue S, Zhan L, Sang R, et al. Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG/IgM ELISA for Sero-Diagnosis. Pathogens. 2024. doi:10.3390/pathogens13070582
BibTeX
@article{Huang2024,
author = {Huang, Jiansheng and Adungo, Ferdinard and Konongoi, Samson Limbaso and Inoue, Shingo and Zhan, Lin and Sang, Rosemary and Ashur, Salame and Kwallah, Allan Ole and Mwau, Matilu and Morita, Kouichi and Yu, Fuxun},
title = {Monoclonal Antibodies for Rift Valley Fever Virus Nucleocapsid: Application in IgG/IgM ELISA for Sero-Diagnosis},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13070582}
}
EUVIMED